Objective: Cross-sectional studies suggest an association between hysterectomy and negative affect. Using prospective data, we examined the associations of negative affect, attitudes toward aging and menopause, premenstrual symptoms, and vasomotor symptoms with elective hysterectomy in midlife.
S ix hundred thousand hysterectomies are performed annually in the United States, making it the most common nonobstetric surgical procedure among women. Approximately 96% of hysterectomies are performed to treat benign conditions such as uterine fibroids and endometriosis 1 and symptoms such as dysfunctional menstrual bleeding. 2 The annual incidence of hysterectomy is highest among women between the ages of 40 and 54 years, 1 in women with lower educational attainment, 3, 4 in women with a high body mass index (BMI), and among African American women. 5 Hysterectomy is effective for treating these conditions but entails substantial risks, leading to long-articulated concerns about the frequency of its use and potential for inappropriate utilization. The mortality rate for hysterectomy is 1 in 1,000, 6 with hospital readmission rates estimated at 7.2%. 7 Morbidity rates have been estimated at 6.1%, 8 with surgical complications including hemorrhage, infection, and internal injury occurring in 1.6% to 18% of patients. 7, 9 Long-term effects may include pain during sexual intercourse, 10 reduced physical functioning, 11 and, in the estimated 55% to 80% of hysterectomies with cooccurring bilateral oopherectomy, 12, 13 increased risk of cardiovascular disease and osteoporosis. 14 Considering these potential risks, there is interest in understanding the nonmedical predictors of hysterectomy. Independent of medical comorbidities, 15 individuals with affective disorders, 16, 17 premenstrual syndrome (PMS), 18, 19 and vasomotor symptoms (VMS) 20 have a higher rate of overall healthcare utilization and report decreased health-related quality of life. 21 Individuals with increased negative affect, including anxiety and depressive symptoms, also report higher rates of somatic and pain symptoms, as well as more bothersome VMS, even controlling for VMS frequency. 22 Women with PMS and negative attitudes about aging and menopause before entering the menopausal transition are more likely to later report menopausal symptoms including VMS, sleep disturbances, genitourinary problems, and depressed mood. [23] [24] [25] [26] [27] [28] The prevalence of menstrual bleeding problems, commonly linked to hysterectomy, increases during the menopausal transition, affecting 10% to 30% of women of reproductive age and up to 50% of perimenopausal women. 29 Thus, among midlife women with negative affect, negative attitudes toward aging and menopause, VMS, and PMS, symptoms such as heavy menstrual bleeding may be more often reported, less tolerated, and thereby more likely to lead to elective hysterectomy during midlife.
An association between negative affect and hysterectomy is supported by cross-sectional studies that suggest that hysterectomized women have more general psychological distress than do their age-matched nonhysterectomized peers. 30, 31 In addition, in studies comparing psychological symptoms before and after hysterectomy, depressive symptoms, anxiety, and psychological morbidity were more common in women scheduled for hysterectomy than would be expected in the general population. [32] [33] [34] [35] [36] However, because psychological symptoms were evaluated at the time of treatment seeking, it is unclear whether reported psychological symptoms were associated with the presenting menstrual problems and/or anxiety about the surgical procedure. 36 Little is known about the individual differences between women who eventually have hysterectomies and those who do not in the years preceding symptom presentation and treatment seeking.
Prospective evaluations of negative affect, attitudes toward aging and menopause, and symptoms before seeking treatment for menstrual problems are needed to increase our understanding of the contribution of these factors to elective hysterectomy. This study enriches previous research by using the large, multiethnic sample of the Study of Women's Health Across the Nation (SWAN). We hypothesized that negative affect (anxiety, depressive symptoms, and perceived stress), negative attitudes toward aging and menopause, and a high burden of VMS and PMS-like symptoms would be associated with an increased likelihood of elective hysterectomy over the menopausal transition.
METHODS

Participants
Participants were from the SWAN, a multisite communitybased prospective study designed to examine the physical and psychological health of women as they undergo the menopausal transition ( Fig. 1 ). Details of the SWAN design and recruitment procedures have been reported elsewhere. 37 All SWAN cohort participants had an intact uterus and at least one ovary and met the additional eligibility criteria: aged 42 to 52 years, not pregnant, not using reproductive hormones, and having one or more menstrual cycles in the 3 months before the interview. Each site recruited non-Hispanic white women and women belonging to a predetermined racial/ethnic minority group: African American women in Pittsburgh, PA, Boston, MA, Detroit, MI, and Chicago, IL; Japanese women in Los Angeles, CA; Hispanic women in Newark, NJ; and Chinese women in the Oakland area of California. Participants were recruited using established sampling techniques, random digit dialing, and random sampling from lists of names or household addresses. Select sites supplemented primary sampling frames to obtain adequate numbers of racial/ethnic minority women. Seventy-three percent of the women selected were contacted and provided information to determine eligibility; 51% (n = 3,302) of eligible women enrolled. Participants returned to their local site facility annually for interviewer-and self-administered questionnaires, a fasting blood draw, and reassessments of physical measures. Data collection for this analysis spanned from 1996 to 2007. The SWAN was approved by the institutional review boards at each site, and each participant provided written informed consent forms. Data collection ceased at the New Jersey SWAN site after 2001 for reasons unrelated to scientific aspects of the project but resulting in a more abbreviated follow-up and the potential for less stable statistical models. Therefore, data from women at this site were excluded from the current analysis.
Design and procedures Elective hysterectomy
At annual follow-up visits 1 to 9, participants were asked whether they have had a Bhysterectomy (an operation to remove your uterus or womb)[ since the previous study visit. Interviewers obtained written consent forms to request medical records for any reported hysterectomy from the surgical facility, and these medical records were reviewed by a boardcertified gynecologist (G.E.W.) to verify hysterectomy and date of surgical operation. Of the 239 reports of hysterectomy, medical records were available for 166 women (68%), confirming self-reports in all but one case. Elective hysterectomy was defined as any hysterectomy occurring in the absence of known or suspected endometrial, uterine, or ovarian cancer; surgical operations that did not meet this criteria (n = 21) were excluded from data analysis. Surgical operations that occurred within the first year were excluded (n = 31) from data analyses because these may have occurred in response to symptoms present at the time of study entry.
Psychosocial and symptom measures
Negative affect. Negative affect, assessed at baseline, included measures of perceived stress, depressive symptoms, and anxiety. Perceived stress in the 2 weeks before the baseline interview was assessed with the four-item Perceived Stress Scale. The extent of stress was measured using a five-point scale, with higher scores indicating greater perceived stress. 38 Depressive symptoms were assessed using the Center for Epidemiological Studies Depression Scale, a 20-item depression symptom scale. Participants indicated how many days in the last week they would agree with statements such as BI felt lonely[ and BI felt that everything I did was an effort.[ A score of 16 or greater out of a possible 60 was used to define the presence of potentially significant depressive symptoms. 39, 40 Anxiety. Anxiety was assessed with four questions asking about the number of days (from 0, Bno days,[ to 4, Bevery day[) in the 2 weeks before the baseline visit in which participants reported Birritability or grouchiness,[ Bfeeling tense or nervous,[ Bheart pounding or racing,[ or Bfeeling fearful for no reason.[ The number of days that participants reported each item was summed into a score ranging from 0 to 16. Significant anxiety was categorized as anxiety scores in the top 20% of the sample (Q4). Attitudes toward aging and menopause. Attitudes toward aging and menopause (neutral/negative, slightly positive, or highly positive) were based on participants' extent of agreement with seven positively correlated statements (Cronbach > = 0.51) about individual and societal views about aging and the menopausal transition, such as Boverall, going through menopause or change of life will be, or was, a positive experience for me.[ A mean score for each woman was calculated, with higher scores indicating more positive attitudes toward aging and menopause. 41 Vasomotor symptoms. Questions about how often (not at all, 1-5 d, 6-8 d, 9-13 d, every day) women experienced hot flashes and night sweats in the 2 weeks before the study visit were used to characterize VMS. Night sweats and hot flashes were combined into a single VMS variable. Responses were categorized as Bnone[ if women reported neither hot flashes nor night sweats and Bany[ if women reported hot flashes, night sweats, or both. PMS-like symptoms. Baseline PMS-like symptoms were based on report of any of 11 psychological and physical symptoms including Banxious, jittery, nervous[ and Bbreast pain, tenderness, or swelling[ during or in the week before at least half of their menstrual periods in the last year. Women were categorized as having PMS-like symptoms if they reported at least one physical symptom, at least one psychological symptom, symptom interference with job or home activities, and dissolution of symptoms within 1 to 3 days of the onset of menses.
Covariates
All proposed covariates (from baseline) included in the univariate analyses were selected on the basis of previously documented associations with hysterectomy 3,5,29,42-44 and retained in multivariate analyses when univariate associations with hysterectomy were P G 0.20. Women were characterized as having menstrual bleeding problems at baseline if they reported heavy or very heavy menstrual flow, flooding or gushing, and clots. Menopause status at baseline was categorized as premenopausal (bleeding in the previous 3 mo with no change in cycle predictability in the past year) or early perimenopausal (bleeding in the previous 3 mo with a decrease in cycle predictability in the past year). Race/ethnicity was selfreported in response to an open-ended question. Age was calculated using date of birth and the date of the baseline visit. Insurance status and education level were self-reported during the screening interview. Self-rated health was assessed by response to the following question: BIn general, would you say your health is excellent, very good, good, fair, or poor? [ 45 Responses were categorized into four categories, with responses of Bfair[ and Bpoor[ collapsed into a single category. BMI was calculated using weight (kilograms) and height (meters squared).
Reproductive hormones
Owing to the relationship between increased estrogen secretion, concomitant follicle-stimulating hormone (FSH) suppression, and factors related to hysterectomy, including fibroid growth, endometriosis, polyps, and abnormal uterine bleeding, reproductive hormones were considered as covariates. Estradiol (E 2 ) and FSH were assessed at baseline and annually thereafter. Reproductive hormone levels were determined from fasting blood samples obtained during the baseline study visit in the 2-to 5-day window of the early follicular phase of the menstrual cycle. FSH was assayed on the ACS-180 automated analyzer (Bayer Diagnostics Corporation, Tarrytown, NY) with a two-site chemiluminometric immunoassay. Interassay coefficients of variation (CVs) were 11.4%, intra-assay CVs were 3.8%, and the lower limit of detection was 1.05 mIU/mL. 46 Duplicate E 2 assays were conducted, with results reported as the arithmetic mean for each participant (CV, 3%-12%). Other assays were single determinations. E 2 was assayed using a rabbit anti-E 2 -6 ACS-180 immunoassay modified to increase sensitivity. The interassay CV was 10.6%, intra-assay CV was 6.4%, and lower limit of detection was 1.0 pg/mL. 47 FSH and E 2 were log transformed to normalize their distributions.
Analytic sample
A total of 2,818 women, including 168 women with hysterectomy not due to preoperative malignancy in visits 2 through 9, comprised the analytic sample. The analytic sample excluded women from the New Jersey site and women who had a hysterectomy in the first year of follow-up. A subset analysis was conducted excluding the data from 48 women without medical records available to verify self-reported hysterectomy. The subset sample was thus composed of 2,770 women, including 120 women with verified hysterectomy.
Statistical analyses
Differences in key baseline factors in women with and without self-reported hysterectomy at study visits 2 to 9 were assessed with W 2 tests for comparisons of categorical variables and t tests for comparisons of continuous variables. All primary explanatory variables associated with hysterectomy at P G 0.05 and covariates associated with hysterectomy at P G 0.20 in univariate analysis were retained in the multiple variable analyses.
The associations of baseline attitudes toward aging and menopause, PMS-like symptoms, and VMS with hysterectomy were estimated with hazard ratios using Cox proportional hazards modeling. To determine the time to event, the self-reported date of hysterectomy was used if a date from medical records was not available. Women who did not report hysterectomy were censored at the date of their last visit; women with self-reported bilateral salingo-oopherectomy without hysterectomy were censored at the date of the visit at which the surgical operation was reported (n = 15). The proportional hazards assumption was tested by including interactions between key predictors and time, which identified one violation of the assumption. A significant interaction between time and menstrual bleeding problems indicated that the impact of baseline bleeding problems decreased over the follow-up period. This interaction was included in the primary model to address nonproportionality. 48 Additional covariates adjusted for in modeling included menstrual bleeding problems, site, race, age, BMI, educational attainment, self-rated health, and FSH (log transformed). All predictors and covariates were entered simultaneously in the final multivariate model. For all analyses, P G 0.05 (two tailed) was considered statistically significant. Analyses were performed with SPSS, version 17.0. 49
RESULTS
Characteristics of the sample
Compared with women in the analytic sample, women who were excluded because of early hysterectomy between baseline and first follow-up had a higher mean BMI (31.6 vs 28.1 kg/m 2 ; P = 0.01), were more likely to report menstrual bleeding problems at baseline (48.1% vs 22.2%; P G 0.001), and were more likely to report PMS-like symptoms at baseline (23.9% vs 13.5%; P = 0.07, trend). There were no other differences on key baseline factors between women who were and were not included in the primary analytic sample (data not shown).
Over the observed 8-year period, 6.0% of participants (n = 168) reported having a hysterectomy for a condition that was not cancer related. This is comparable with expected rates a for all-cause hysterectomy among women aged 45 to 54 years in the general population. 13 The most common preoperative symptoms and diagnoses identified in the available medical records (n = 120, 71%) were suspected or diagnosed uterine fibroids (n = 82, 66.1%), suspected or diagnosed menorrhagia (n = 71, 57.3%), and chronic pelvic pain (n = 34, 27.4%). Suspected or diagnosed fibroids largely explained the presentation of menorrhagia (n = 62, 87.3%) and chronic pelvic pain (n = 30, 88.2%) in this sample. According to medical records, 77 (64%) women had a hysterectomy with concomitant bilateral oophorectomy, 10 (8%) women had a hysterectomy with concomitant unilateral oophorectomy, and 33 (28%) women had a hysterectomy with ovarian conservation. The median time to hysterectomy was 3.9 years from baseline (range, 1.1-9.4 y).
Baseline predictors of subsequent elective hysterectomy
Compared with women without hysterectomy, women who reported hysterectomy were more likely to report menstrual bleeding problems, were slightly younger (45.4 vs 45.9 y; P = 0.04), had a higher BMI (29.6 vs 28.0 kg/m 2 ; P = 0.01), and had lower FSH values (18.4 vs 24.4 mlU/mL; P G 0.001) at the study baseline. The groups also varied by site, race/ ethnicity, and educational attainment ( Table 1) .
The presence of VMS, a more positive attitude toward aging and menopause, significant anxiety, and PMS-like symptoms at baseline were each associated with hysterectomy in the univariate analysis (Table 2 ). There was also a significant interaction between menstrual bleeding problems and time to hysterectomy; bleeding problems at baseline were associated with increased risk of subsequent hysterectomy, but this association decreased over time.
VMS and a more positive attitude toward aging and menopause continued to predict subsequent hysterectomy after adjusting for known risk factors including menstrual bleeding problems, race/ethnicity, socioeconomic status (SES), physical health, age, BMI, FSH levels, and the interaction between time and bleeding problems. The associations between PMS-like symptoms and significant anxiety and hysterectomy were no longer seen in the fully adjusted model. Having a low baseline FSH level and being African American were also associated with an increased likelihood of subsequent hysterectomy (Table 3) .
Baseline predictors of medical recordYverified elective hysterectomy
In the subset analysis limited to medical recordYverified hysterectomies, only women with menstrual bleeding problems were at significantly increased risk for hysterectomy after adjusting for other known risk factors including menstrual bleeding problems, race/ethnicity, SES, physical health, age, BMI, and FSH levels. There was no evidence of variability of the effect of menstrual bleeding problems over time in this sample, so this interaction was not included in the subset analysis. The increased risk for hysterectomy among African American women and women with lower FSH levels persisted in this subset, although the trend for positive attitudes toward aging and menopause and the association with VMS did not (Table 4 ). However, the hazard ratios were reduced only slightly, from 1.75 in the full sample to 1.67 in the subset analyses for highly positive attitudes. Power to detect these effects in the subset was 49% compared with 67% in the full sample, due to the smaller sample size and lower event rate.
DISCUSSION
This study expanded the perspective of previous research on the relationship between hysterectomy and negative affect by addressing the question with prospective data as opposed to a cross-sectional approach. Although negative affect is generally high when assessed before hysterectomy, 36 we found that measures of negative affect, including anxiety, depressive symptoms, and perceived stress, did not increase the likelihood of hysterectomy over the menopausal transition. Cross-sectional studies may suffer from a lack of nonhysterectomized comparison groups and from assessment close to the time of surgical operation. In contrast, we compared women with and without a subsequent hysterectomy using measures of affect assessed, on average, 4 years before hysterectomy. Our results suggest that negative affect in the years before treatment seeking is not predictive of subsequent hysterectomy.
Negative attitudes toward aging and menopause were also not associated with elective hysterectomy. Contrary to our hypothesis, a more positive attitude toward aging and menopause was related to subsequent elective hysterectomy. Although negative attitudes toward aging and menopause have not been specifically linked to hysterectomy, they have been associated with increased reporting of menopausal symptoms and depressed mood. 23, 25 It was assumed a priori that negative attitudes toward aging and menopause in the early transition would influence symptom sensitivity and tolerance over the transition and increase the likelihood of treatment seeking leading to hysterectomy. Instead, women with a positive outlook toward their imminent menopause may be more willing to take action via surgical menopause in the face of problematic symptoms.
VMS was independently and positively associated with having a hysterectomy. After adjustment for risk factors including menstrual bleeding problems, women with VMS in the early menopausal transition were 43% more likely than those without to have an elective hysterectomy. This is the first known study to link VMS with subsequent hysterectomy. Hormonal variability in the menopausal transition may play a role in the underlying etiology of VMS as well as the development of menstrual symptoms associated with hysterectomy. 50 In addition, subjective reporting of VMS may be related to an increased awareness of all negative symptoms due to somatic sensitivity and symptom amplification, 51 evidence of which has been seen in past studies linking VMS to increased symptom sensitivity. 52, 53 The negative effects of VMS on quality of life 20 may also increase the likelihood of menstrual bleeding problems being less tolerated, and the effect of VMS on healthcare utilization may increase the risk of seeking and receiving treatment for the conditions and symptoms leading to a hysterectomy.
PMS has not been specifically linked to hysterectomy in the literature, but a connection was hypothesized based on its associations with increased reporting of menopausal symptoms, [26] [27] [28] increased overall healthcare utilization, and decreased health-related quality of life. 18, 19 In this sample, PMS-like symptoms were independently associated with hysterectomy, but the association did not persist after adjusting for known risk factors. Women with PMS-like symptoms were also more likely to report VMS and menstrual bleeding problems, which had strong associations with hysterectomy. Women whose data were excluded from analysis because of preoperative malignancy or hysterectomy shortly after baseline measurement were also more likely to report PMS-like symptoms.
Occasional or persistent heavy menstrual bleeding is reported by one third of women, with prevalence increasing to 50% of women in the years before menopause. 29 Heavy bleeding is the main presenting symptom in 50% to 70% of all hysterectomies performed, 2 and we anticipated that a high reported burden of menstrual bleeding problems would be associated with an increased likelihood of elective hysterectomy over the menopausal transition. Consistent with this expectation, menstrual bleeding problems were predominant in the women whose data were excluded from analysis because of preoperative malignancy or hysterectomy within 12 months of the baseline measurement and were consistently associated with elective hysterectomy, even after adjustment for risk factors. The association was retained in subset analyses excluding women without medical record confirmation of hysterectomy. The presence of menstrual bleeding problems assessed an average of 4 years before hysterectomy more than quadrupled the risk of subsequent hysterectomy over the observed period, even after accounting for the decreasing impact of menstrual bleeding over time.
Additional findings deserve mention. In our sample, there was an increased risk for hysterectomy among African American women. This finding is consistent with the literature, in which hysterectomy rates are usually higher among African American women compared with other groups. 5, 43, 54, 55 High BMI, 5 smoking, 44 and poor health 56 are associated with past hysterectomy in community samples and are often attributed, in part, to poor health before surgical operation, 31 but there was no effect of self-rated health or smoking status in the univariate analysis and no effect of BMI in the fully adjusted model. Women whose data were excluded from analysis because of preoperative malignancy or hysterectomy soon after baseline measurement had significantly higher BMI than did women in the analytic sample, which may have obscured a relationship between these factors. Despite past findings that SES is lower in women who have had a hysterectomy, [3] [4] [5] 30, 44, 54, [57] [58] [59] [60] [61] the independent association of educational attainment with hysterectomy in our sample did not persist in the adjusted analysis. Income, ability to pay for basics, and health insurance status were also not significantly associated with hysterectomy. Differences in demographic risk factors between our findings and those of past investigations may be due to the prospective design and older age of our sample. In light of our findings, midlife may be a time when some conventional risk factors for hysterectomy are less relevant.
In a subset analysis excluding women reporting hysterectomy without available medical records, VMS no longer had an association with hysterectomy, whereas menstrual bleeding problems continued to contribute to hysterectomy risk. Being African American and having lower FSH levels at baseline also continued to be associated with increased risk. Self-report of hysterectomy has been shown to be accurate when validated against medical records. 62 This was true in our sample of women as well. In our cohort, the differences in these analyses are probably due to a loss of statistical power, rather than a more accurate reflection of hysterectomy in the secondary analysis.
Several limitations of this study should be noted. As reflected in the fact that only half of those women who were eligible for SWAN chose to enroll in the study, women who chose to participate in SWAN and continue to adhere to the time commitment of annual visits are highly motivated and may differ from the general population. The effects of duration, frequency, and stability of time-varying measures, as well as their changing influences closer to the time of surgical operation, were not examined. Although our interest was in examining these factors with distance from the event, there may be additional information to be gained in subsequent analyses that address the influence of time-varying characteristics of these factors. Because the data relied heavily on self-report, information may exhibit response bias or subjective inaccuracies. Because predictors of elective hysterectomy among women in midlife may differ from predictors among younger women, findings should not be generalized to younger populations. Furthermore, women with previous hysterectomy were ineligible for SWAN enrollment, and therefore, women who had a hysterectomy after enrollment may not be representative of all women with hysterectomy. This sample characteristic may have contributed to differences between the results of this study and others.
Despite these limitations, the study also had considerable strengths. This study used a large, well-characterized, multiethnic population-based sample of women in midlife. The incidence of hysterectomy was collected over an 8-year period, allowing for observations across a range of a participant ages and stages in the menopausal transition. This study was unique in prospectively evaluating the influence of a variety of factors on subsequent elective hysterectomy.
CONCLUSIONS
This study contributes to our limited knowledge about the antecedents of elective hysterectomy among women in midlife. Previous findings of associations between negative affect and hysterectomy do not fully address the role of affect in prospectively influencing decisions by women and their physicians regarding elective hysterectomy. Our results should assure physicians that treatment seeking is not always a sign of depression, anxiety, or negative expectations about menopause, whereas menstrual bleeding problems are the most influential factor for hysterectomy. However, the length of time between our assessment of menstrual bleeding problems and subsequent hysterectomy, a mean of 4 years, suggests that these problems are endured for a long period. In addition, the association of VMS in the early menopausal transition with subsequent hysterectomy may indicate that a symptomatic menopause is linked to an increased occurrence of or sensitivity to the symptoms and conditions precipitating hysterectomy. Finally, our findings suggest that women who elect hysterectomy are not choosing this avenue because of negative affect and poor attitudes toward aging.
